Aligning Preclinical InVivo Models of Parkinson’s Disease (PD) with Biological Classifications of PD

• Examine why models differ in their degree of predictive validity for symptomatic and disease modifying therapies
• Where do current models of PD sit within biological classifications of PD?
• What should next generation models of PD focus on?

Speakers:

Patrick Howson

Chief Innovation Officer

Atuka